These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7103519

  • 21. Behçet's disease, palmoplantar pustulosis and HLA-B27 treatment with thalidomide.
    Hamza M.
    Clin Exp Rheumatol; 1990; 8(4):427. PubMed ID: 2397633
    [No Abstract] [Full Text] [Related]

  • 22. Erythema nodosum following thalidomide therapy for Behçet's disease.
    Viraben R, Dupré A.
    Dermatologica; 1988; 176(2):107. PubMed ID: 3371520
    [No Abstract] [Full Text] [Related]

  • 23. Exacerbation of psoriasis by thalidomide in Behçet's syndrome.
    Dobson CM, Parslew RA.
    Br J Dermatol; 2003 Aug; 149(2):432-3. PubMed ID: 12932265
    [No Abstract] [Full Text] [Related]

  • 24. The management of Behçet's syndrome: how are we doing?
    Yazici H, Yurdakul S, Hamuryudan V.
    Clin Exp Rheumatol; 1999 Aug; 17(2):145-7. PubMed ID: 10342039
    [No Abstract] [Full Text] [Related]

  • 25. Successful treatment of Behçet's syndrome in an African female patient with thalidomide.
    Lewis DA, Amerasinghe CN, Murphy SM.
    Int J STD AIDS; 1996 Aug; 7(7):518-20. PubMed ID: 9116070
    [No Abstract] [Full Text] [Related]

  • 26. [Behcet's disease therapy review].
    Vidaller Palacín A, Robert Olalla J, Sanuy Jiménez B, Rufi Rigau G, Folch Civit J, Charte González A.
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [Abstract] [Full Text] [Related]

  • 27. Thalidomide revisited.
    D'Arcy PF, Griffin JP.
    Adverse Drug React Toxicol Rev; 1994 Nov; 13(2):65-76. PubMed ID: 7918899
    [No Abstract] [Full Text] [Related]

  • 28. [Current use of thalidomide].
    Revuz J.
    Ann Dermatol Venereol; 1990 Nov; 117(4):313-21. PubMed ID: 2195968
    [No Abstract] [Full Text] [Related]

  • 29. [An analysis of adverse drug reactions of thalidomide in treatment of immune-related bowel diseases].
    Luo HQ, Tan B, Lü H, Qian JM.
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):726-9. PubMed ID: 24314159
    [Abstract] [Full Text] [Related]

  • 30. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L, Horowitz I, Kay B.
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [Abstract] [Full Text] [Related]

  • 31. [Speculative ameloriation of arthritis in Behcet disease with thalidomide. A case report].
    Trèves R, Arnaud M, Jacob P, Lubeau M, Tabaraud F, Burki F, Desproges-Gotteron R.
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):585. PubMed ID: 6533773
    [No Abstract] [Full Text] [Related]

  • 32. Successful treatment by thalidomide therapy of intestinal Behçet's disease associated with trisomy 8 myelodysplastic syndrome.
    Wei Q, Zhang X, Peng Y, Chen K, Xu S, Huang X, Zhang L, Xie Q, He Y, Li Y, Chai J.
    Rheumatology (Oxford); 2021 Jun 18; 60(6):e200-e202. PubMed ID: 33331901
    [No Abstract] [Full Text] [Related]

  • 33. Thalidomide use.
    Am Fam Physician; 1983 Dec 18; 28(6):237. PubMed ID: 6650339
    [No Abstract] [Full Text] [Related]

  • 34. Thalidomide therapy for juvenile-onset entero-Behçet disease.
    Yasui K, Misawa Y, Shimizu T, Komiyama A, Kawakami T, Mizoguchi M.
    J Pediatr; 2003 Nov 18; 143(5):692-4. PubMed ID: 14649666
    [No Abstract] [Full Text] [Related]

  • 35. Thalidomide: focus on its employment in rheumatologic diseases.
    Ossandon A, Cassarà EA, Priori R, Valesini G.
    Clin Exp Rheumatol; 2002 Nov 18; 20(5):709-18. PubMed ID: 12412207
    [Abstract] [Full Text] [Related]

  • 36. Intestinal involvement in children with Behçet's disease.
    Marchetti F, Trevisiol C, Ventura A.
    Lancet; 2002 Jun 15; 359(9323):2115. PubMed ID: 12086789
    [No Abstract] [Full Text] [Related]

  • 37. Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis.
    Torras H, Lecha M, Mascaro JM.
    Arch Dermatol; 1982 Nov 15; 118(11):875. PubMed ID: 7138037
    [No Abstract] [Full Text] [Related]

  • 38. [Adamantiades-Behçet's disease. Clinical review].
    Störk S, Kneitz C, Bröcker EB, Hoyer C, Ertl G, Angermann CE.
    Med Klin (Munich); 2008 Mar 15; 103(3):143-52. PubMed ID: 18344064
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behçet's disease-like animal model.
    Sohn S, Lee ES, Lee SI, Kim YA, Kwon HJ, Bang D, Lee S.
    Adv Exp Med Biol; 2003 Mar 15; 528():585-9. PubMed ID: 12918770
    [No Abstract] [Full Text] [Related]

  • 40. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM, Smith NJ, Powell RJ.
    Ann Rheum Dis; 1994 Dec 15; 53(12):828-32. PubMed ID: 7864692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.